Publicaciones en las que colabora con Abel Crespo Gavilán (10)

2022

  1. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1Antagonists

    Journal of Medicinal Chemistry, Vol. 65, Núm. 3, pp. 2091-2106

2021

  1. 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition

    Journal of medicinal chemistry, Vol. 64, Núm. 1, pp. 458-480

2017

  1. 3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation

    ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933

  2. Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists

    Chemistry of Heterocyclic Compounds, Vol. 53, Núm. 3, pp. 316-322

2016

  1. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes

    Journal of Medicinal Chemistry, Vol. 59, Núm. 5, pp. 1967-1983

2013

  1. Discovery of 3,4-dihydropyrimidin-2(1 H)-ones as a novel class of potent and selective A2B adenosine receptor antagonists

    ACS Medicinal Chemistry Letters, Vol. 4, Núm. 11, pp. 1031-1036

  2. Three-component assembly of structurally diverse 2-aminopyrimidine-5- carbonitriles

    ACS Combinatorial Science, Vol. 15, Núm. 7, pp. 370-378

2011

  1. Convergent assembly of structurally diverse quinazolines

    Organic and Biomolecular Chemistry, Vol. 9, Núm. 2, pp. 351-357

2008

  1. Synthetic applications of polystyrene-supported 1,1,3,3- tetramethylguanidine

    Combinatorial Chemistry and High Throughput Screening, Vol. 11, Núm. 10, pp. 843-847

2006

  1. Pyridazines part 41: Synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl) pyridazin-3(2H)-ones

    Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 4, pp. 1080-1083